Summary Slide.png (101.55 kB)
Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study
figure
posted on 2020-03-31, 10:00 authored by Ken Yoshikawa, Akira Tsuchiya, Tomoyuki Kido, Tomohiro Ota, Keiko Ikeda, Mika Iwakura, Yoshikazu Maeda, Shinichiroh MaekawaThe above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC. 2020.
